Skip to main content
Signal8

DSwiss Inc (DQWS)

DSwiss, Inc. is a biotech-nutraceutical company that supplies a comprehensive range of health and beauty products. Its market reach extends across Malaysia, Singapore, Indonesia, Taiwan, Macau, Hong Kong, and China. The company's product line includes specialized items like DSwiss coffee, targeting digestive well-being, and DSwiss kiwi, formulated to boost the immune system, improve skin tone, help manage blood pressure, and minimize the risk of heart disease and stroke. DSwiss Triple SC focuses on stem cell-related benefits. For skincare, DSwiss offers the DSwiss silk mask, designed for dry, damaged, and sensitive skin; the DSwiss coffee slimming scrub, a natural body exfoliant for removing impurities; the cooling DSwiss peppermint slimming gel; the DSwiss new age essence, which provides nutrients to moisturize, brighten, and refresh tired-looking skin; and the DSwiss enlighten essence cream, a light, nourishing formula. DSwiss also provides medical eyewear under the name DSwiss BioSpec. Its broader health offerings include Genmune-Pro, which strengthens the human immune system by enhancing digestive health; SkinEra, a solution for various skin conditions such as acne, pimples, atopic dermatitis, dry skin, and allergic rashes; SensiBath gel; and SuiSu hand purifiers, sanitizers, and air sanitizers. Specialized supplements include MasterLiv for liver support, MasterHeart for maintaining optimal heart health and smooth blood circulation, and WellG, which delivers essential nutrients for sugar metabolism and energy production. In addition to its product range, DSwiss, Inc. offers diagnostic and analytical equipment. This includes the DSwiss quantum magnetic analyzer, a device that interprets body energy fields to assess health status and offer recommendations, and an AI skin analyzer machine, a facial camera designed to collect skin image data. The company also provides turnkey private label manufacturing services and DNA microarray genotyping services. Furthermore, DSwiss supplies a variety of medical consumables, such as surgical gowns and gloves, 3-ply face masks, N95 masks, protective goggles, body infrared thermometers, disposable bedsheets, and stretcher covers. DSwiss, Inc. was incorporated in 2015 and is headquartered in Kuala Lumpur, Malaysia.

Sector: Perfumes, Cosmetics & Other Toilet Preparations

Industry: Household & Personal Products

DSwiss, Inc. logo

DSwiss, Inc.

OTC:DQWSConsumer Defensive
Mkt Cap-
Float18.91M
O/S-
Inst Own-
SI<0.1%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$2.92M
Net Income-$77K
Total Assets$677K
Free Cash Flow-$135K
Debt & Equity
Debt 103%
Total Debt$282K
Total Equity-$9K
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in DQWS's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$677K
Liabilities$686K
Accounts Receivable$21K
Accounts Payable$113K
Inventory$2K
PP&E (Net)$345K
Goodwill$0
Intangible Assets$409
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Revenue$2.92M$3.11M$1.47M$1.85M$1.96M$1.35M$274K$220K$181K$137K$155K$458K$521K
YoY Growth-6.2%111.8%-20.5%-5.6%45.3%392.5%24.3%21.3%32.2%-11.5%-66.2%-12.0%-
Cost of Revenue$2.36M$2.49M$1.11M$1.4M$1.46M$980K$182K$178K$36K$65K$84K$194K$190K
Gross Profit$565K$623K$359K$445K$499K$367K$92K$42K$145K$72K$71K$264K$330K
Gross Margin19.3%20.0%24.4%24.1%25.5%27.3%33.5%19.0%80.1%52.7%45.8%57.6%63.4%
Research and Development$0$0$0$0$0$0$0$0$0$0$0$0$0
Selling, General, and Administrative$650K$604K$411K$445K$353K$333K$290K$237K$205K$395K$80K$225K$269K
Other$1K$0$0$1K$1K$1K$151K$185K$966$13$107$0$0
Total Operating Expenses$651K$604K$368K$446K$355K$335K$441K$421K$205K$395K$80K$246K$284K
Operating Income (EBIT)-$86K$20K-$53K$4K$153K$138K-$286K-$379K-$59K-$323K-$9K$18K$46K
Operating Margin-2.9%0.6%-3.6%0.2%7.8%10.2%-104.5%-172.4%-32.6%-235.2%-5.9%3.9%8.8%
Interest Expense$14K$2K$3K$6K$3K$3K$2K$0$0$0$0$0$0
Interest Income$0$0$0$0$0$0$0$8K$0$0$0$0$0
Other Income (Expense)$25K$12K$4K-$1K$6K-$3K-$2K-$38K-$59K-$23K-$120K-$21K-$15K
Income Before Tax (EBT)-$61K$30K-$49K-$2K$150K$30K-$295K-$371K-$285K$516K-$129K$18K$46K
Income Tax Expense$16K$8K$657$516$176$3K$0$16K$966$1.03M-$26$424$1K
Net Income-$77K$22K-$50K-$14K$173K$27K-$352K-$351K-$284K-$508K-$129K$17K$45K
Net Income Margin-2.6%0.7%-3.4%-0.8%8.9%2.0%-128.6%-159.6%-156.8%-370.4%-83.4%3.8%8.6%
Supplementary Data
EPS-0.000.00-0.00-0.000.000.00-0.00-0.00-0.00-0.00-0.000.000.00
Diluted EPS-0.000.00-0.00-0.000.000.00-0.00-0.00-0.00-0.00-0.000.000.00
Weighted Average OS206.90M206.90M206.90M206.90M206.90M206.90M206.90M206.90M206.43M203.46M205.34M206.90M206.90M
EBITDA$18K$50K$20K$77K$219K$202K-$227K-$347K-$259K-$496K-$111K$38K$60K
EBITDA Margin0.6%1.6%1.4%4.2%11.2%15.0%-83.1%-157.4%-142.6%-361.4%-71.5%8.4%11.5%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Assets
Current Assets
Cash and Cash Equivalents$285K$397K$249K$214K$235K$158K$48K$189K$499K$783K$437K$34K$100K
Short-Term Investments$0$0$0$0$0$0$0$0$0$0$0$520$553
Cash and Short-Term Investments$285K$397K$249K$214K$235K$158K$48K$189K$499K$783K$437K$34K$101K
Accounts Receivable$21K$75K$42K$18K$3K$10K$10K$32K$21K$4K$8K$1K$9K
Inventory$2K$3K$7K$7K$17K$38K$17K$15K$19K$34K$2K$17K$16K
Other Current Assets$15K$20K$17K$20K$53K$32K$118K$35K$65K$452$424$618$553
Total Current Assets$332K$498K$317K$262K$308K$239K$200K$277K$607K$837K$451K$55K$127K
Long-Term Assets
Property, Plant & Equipment Net$345K$137K$48K$117K$186K$100K$160K$93K$57K$75K$43K$68K$53K
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$409$1K$2K$3K$4K$6K$7K$10K$10K$10K$3K$0$0
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0-$120K$0-$105K-$166K$0$0$0$0$0$0
Total Long-Term Assets$345K$138K$51K$120K$190K$105K$166K$103K$67K$85K$46K$68K$53K
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$677K$636K$367K$382K$498K$344K$366K$379K$673K$922K$496K$123K$180K
Liabilities
Current Liabilities
Accounts Payable$113K$153K$99K$30K$11K$1K$458$28K$4K$5K$2K$1K$4K
Short-Term Debt$0$0$0$0$0$0$0$0$0$638K$0$0$0
Current Income Tax Payable$2K$108$0$0$175$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Liabilities$0$230K$115K$100K$0$279K$295K$63K$51K$37K$39K$43K$49K
Total Current Liabilities$465K$484K$295K$245K$319K$382K$382K$129K$74K$705K$58K$60K$131K
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$0$0$0$0$214K$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Long-Term Liabilities$221K$78K$16K$38K$105K$32K$89K$49K$12K$15K$214K$0$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$686K$562K$311K$284K$424K$414K$470K$178K$86K$720K$271K$60K$131K
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$21K$21K$21K$21K$21K$21K$21K$21K$21K$20K$20K$0$0
Retained Earnings-$1.46M-$1.39M-$1.41M-$1.32M-$1.31M-$1.48M-$1.49M-$1.2M-$854K-$569K-$61K$68K$51K
Comprehensive Income & Other$39K$46K$50K-$6K-$33K-$28K-$35K-$21K-$7K-$38K-$13K-$5K-$2K
Other Stockholders' Equity$1.43M$1.44M$1.45M$1.39M$1.36M$1.37M$1.36M$1.37M$1.39M$719K$266K-$5K-$2K
Total Equity-$9K$74K$56K$86K$73K-$95K-$109K$190K$555K$170K$225K$63K$49K
Minority Interest$0$0$0$12K$589$26K$5K$12K$32K$33K$0$0$0
Total Liabilities and Equity$677K$636K$367K$370K$498K$319K$361K$367K$641K$890K$496K$123K$180K
Supplementary Data
Total Debt$282K$106K$37K$100K$167K$90K$142K$56K$16K$656K$214K$0$0
Net Debt-$3K-$291K-$212K-$115K-$67K-$68K$93K-$132K-$483K-$127K-$224K-$34K-$100K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Operating Activities
Net Income-$77K$30K-$50K-$2K$150K$30K-$295K-$351K-$284K-$508K-$129K$17K$45K
Depreciation & Amortization$65K$19K$66K$73K$66K$64K$66K$25K$27K$20K$19K$21K$14K
Deferred Income Tax$0$0$0$0$0$0$0$0$0$0$0$0$0
Stock-Based Compensation$0$0$0$0$0$0$0$0$0$0$0$0$0
Changes in Working Capital:
  Accounts Receivable$62K-$22K$26K-$16K$7K-$638$3K-$2K-$3K$13K-$8K$8K-$8K
  Inventory$1K$4K$329$9K$20K-$20K-$2K$4K$17K-$32K$13K-$2K-$9K
  Accounts Payable-$55K$32K$25K$15K$10K$745-$27K$24K$2K-$3K$442$0$0
  Other Working Capital-$59K$127K-$24K-$56K$2K-$125K$42K$66K-$104K-$32K$7K-$69K$58K
Total Working Capital Change-$51K$141K$28K-$48K$38K-$146K$16K$92K-$88K-$55K$13K-$62K$40K
Other Non-Cash Items-$31K-$7K$419-$822-$3K$111K$34K$7K$38K$55K$31K-$4K$2K
Net Cash from Operating-$94K$183K$45K$22K$252K$59K-$180K-$250K-$346K-$550K-$98K-$29K$101K
Investing Activities
Capital Expenditures-$41K-$106K-$373-$14K-$62K-$2K-$2K-$84K-$2K-$63K-$8K-$39K-$54K
Acquisitions$33K$0$0$0$0$0$0$19K$0$41K$0$0$0
Purchases of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Investing Activities$0$291$1$0$0$0$0$19K-$1K-$8K-$3K$0$0
Net Cash from Investing-$8K-$105K-$372-$14K-$62K-$2K-$2K-$65K-$2K-$21K-$8K-$39K-$54K
Financing Activities
Debt Repaid$35K-$68K$16K$16K-$34K$8K$7K-$41K$642K-$443K-$214K--
Common Stock Issuance$0$0$0$0$0$0$0$0$638K$478K$300K$0$0
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$0$0-$38K-$70K$113K$85K$669$19K$60K$171$0-$49K
Net Cash from Financing-$35K$68K-$16K-$54K-$79K$105K$78K$42K$16K$940K$513K$0-$49K
Forex Effect$25K$3K$6K$26K-$34K-$52K-$37K-$36K$47K-$22K-$4K$1K-$441
Net Change in Cash-$112K$148K$35K-$20K$77K$110K-$140K-$310K-$284K$346K$403K-$67K-$3K
Supplementary Data
Operating Cash Flow-$94K$183K$45K$22K$252K$59K-$180K-$250K-$346K-$550K-$98K-$29K$101K
Capital Expenditure-$41K-$106K-$373-$14K-$62K-$2K-$2K-$84K-$2K-$63K-$8K-$39K-$54K
Free Cash Flow-$135K$77K$45K$8K$190K$57K-$182K-$334K-$348K-$613K-$106K-$68K$47K
Cash at Beginning$397K$249K$214K$235K$158K$48K$189K$499K$783K$437K$34K$100K$103K
Cash at End$285K$397K$249K$214K$235K$158K$48K$189K$499K$783K$437K$34K$100K